932
Views
29
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck

, , , , , & show all
Pages 300-305 | Received 01 May 2005, Published online: 26 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Takashi Yamatodani, Bo Holmqvist, Elisabeth Kjellén, Anders Johnsson, Hiroyuki Mineta & Johan Wennerberg. (2012) Using intravital microscopy to observe bevacizumab-mediated anti-angiogenesis in human head and neck squamous cell carcinoma xenografts. Acta Oto-Laryngologica 132:12, pages 1324-1333.
Read now
Yutaka Sasaki, Elisabeth Kjellén, Hiroyuki Mineta, Johan Wennerberg & Lars Ekblad. (2009) No direct effects of erythropoietin beta on a head and neck squamous cell carcinoma cell line which is growth stimulated in vivo. Acta Oncologica 48:7, pages 1062-1069.
Read now

Articles from other publishers (27)

Yali Cheng, Shaoming Li, Ling Gao, Keqian Zhi & Wenhao Ren. (2021) The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma. Frontiers in Oncology 11.
Crossref
Anas H. A. Abu-Humaidan, Lars Ekblad, Johan Wennerberg & Ole E. Sørensen. (2020) EGFR modulates complement activation in head and neck squamous cell carcinoma. BMC Cancer 20:1.
Crossref
Want Tao, Zeng Li-Juan, Li Kan, Li Jing-Yuan, Liu Xiang-Qi & Liang Yu-Jie. 2020. Tumor Microenvironments in Organs. Tumor Microenvironments in Organs 49 78 .
Manzar Alam, Tanushree Kashyap, Prajna Mishra, Aditya K. Panda, Siddavaram Nagini & Rajakishore Mishra. (2018) Role and regulation of proapoptotic Bax in oral squamous cell carcinoma and drug resistance. Head & Neck.
Crossref
Sheng He, Bo Hu, Chao Li, Ping Lin, Wei-Guo Tang, Yun-Fan Sun, Fang-You-Min Feng, Wei Guo, Jia Li, Yang Xu, Qian-Lan Yao, Xin Zhang, Shuang-Jian Qiu, Jian Zhou, Jia Fan, Yi-Xue Li, Hong Li & Xin-Rong Yang. (2018) PDXliver: a database of liver cancer patient derived xenograft mouse models. BMC Cancer 18:1.
Crossref
P Ramos‐García, JA Gil‐Montoya, C Scully, A Ayén, L González‐Ruiz, FJ Navarro‐Triviño & MA González‐Moles. (2017) An update on the implications of cyclin D1 in oral carcinogenesis. Oral Diseases 23:7, pages 897-912.
Crossref
Pablo Ramos-García, Isabel Ruiz-Ávila, José Antonio Gil-Montoya, Ángela Ayén, Lucía González-Ruiz, Francisco José Navarro-Triviño & Miguel Ángel González-Moles. (2017) Relevance of chromosomal band 11q13 in oral carcinogenesis: An update of current knowledge. Oral Oncology 72, pages 7-16.
Crossref
Dennis O. Adeegbe & Yan Liu. 2017. Ex Vivo Engineering of the Tumor Microenvironment. Ex Vivo Engineering of the Tumor Microenvironment 13 40 .
Gustaf Lindgren, Elisabeth Kjellén, Johan Wennerberg & Lars Ekblad. (2016) Wound‐healing factors can prime head and neck cancer cells to increase their tumor‐forming capacity. The Laryngoscope 126:6.
Crossref
Gustaf Lindgren, Lars Ekblad, Johan Vallon-Christersson, Elisabeth Kjellén, Maria Gebre-Medhin & Johan Wennerberg. (2014) Erythropoietin suppresses the activation of pro-apoptotic genes in head and neck squamous cell carcinoma xenografts exposed to surgical trauma. BMC Cancer 14:1.
Crossref
Lars Ekblad, Gustaf Lindgren, Emma Persson, Elisabeth Kjellén & Johan Wennerberg. (2013) Cell-line-specific stimulation of tumor cell aggressiveness by wound healing factors – a central role for STAT3. BMC Cancer 13:1.
Crossref
Xiangming Ji, Zhiwei Wang, Andreea Geamanu, Arvind Goja, Fazlul H Sarkar & Smiti V. Gupta. (2012) Delta‐tocotrienol suppresses Notch‐1 pathway by upregulating miR‐34a in nonsmall cell lung cancer cells. International Journal of Cancer 131:11, pages 2668-2677.
Crossref
XIAN-LU ZHUO, JUN-JUN LING, HOU-YU ZHAO, YAN ZHOU, YU-FENG SONG & YING-HUI TAN. (2012) Lack of association of the cyclin D1 G870A variation with oral carcinoma risk: Evidence from 2,404 subjects. Experimental and Therapeutic Medicine 4:4, pages 748-754.
Crossref
John J. Tentler, Aik Choon Tan, Colin D. Weekes, Antonio Jimeno, Stephen Leong, Todd M. Pitts, John J. Arcaroli, Wells A. Messersmith & S. Gail Eckhardt. (2012) Patient-derived tumour xenografts as models for oncology drug development. Nature Reviews Clinical Oncology 9:6, pages 338-350.
Crossref
Goro Oshima, Johan Wennerberg, Takashi Yamatodani, Elisabeth Kjellén, Hiroyuki Mineta, Anders Johnsson & Lars Ekblad. (2011) Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines. Journal of Cancer Research and Clinical Oncology 138:3, pages 491-499.
Crossref
L. Kastl, I. Brown & A. C. Schofield. (2011) miRNA-34a is associated with docetaxel resistance in human breast cancer cells. Breast Cancer Research and Treatment 131:2, pages 445-454.
Crossref
Michiel W. M. van den Brekel, C. L. Zuur, Stephen P. Malkoski & Xiao-Jing Wang. 2011. Head and Neck Cancer. Head and Neck Cancer 191 200 .
Elodie E. Noel, Marc Yeste-Velasco, Xueying Mao, Jackie Perry, Sakunthala C. Kudahetti, Ningfeng F. Li, Swee Sharp, Tracy Chaplin, Liyan Xue, Alan McIntyre, Ling Shan, Thomas Powles, R. Tim D. Oliver, Bryan D. Young, Janet Shipley, Daniel M. Berney, Simon P. Joel & Yong-Jie Lu. (2010) The Association of CCND1 Overexpression and Cisplatin Resistance in Testicular Germ Cell Tumors and Other Cancers. The American Journal of Pathology 176:6, pages 2607-2615.
Crossref
R. Sahoo, V. Chittibabu, G. Patil, S. Rao, S. Thakur, G. Dhondalay, A.J. Kulkarni, A. Banerjee, B.S. Ajaikumar, A. Korlimarla, A. Nargund, R.N. Niti, K.S. Gopinath, Shilpa Prabhudesai & R.M. Raghavendra. (2009) Relationship between molecular markers and treatment response in a retrospective cohort of Indian patients with primary carcinoma of the larynx. Oral Oncology 45:12, pages e216-e221.
Crossref
Hui-Shen Liu, Hsuan-Hsuan Lu, Mann-Tin Lui, En-Hao Yu, Wilma Shen, Yu-Ping Chen, Kuo-Wei Chang & Hsi-Feng Tu. (2009) Detection of copy number amplification of cyclin D1 (CCND1) and cortactin (CTTN) in oral carcinoma and oral brushed samples from areca chewers. Oral Oncology 45:12, pages 1032-1036.
Crossref
Yu-Yi Hou, Mu-Ling Wu, Yu-Chun Hwang, Fang-Rong Chang, Yang-Chang Wu & Chin-Chung Wu. (2009) The natural diterpenoid ovatodiolide induces cell cycle arrest and apoptosis in human oral squamous cell carcinoma Ca9-22 cells. Life Sciences 85:1-2, pages 26-32.
Crossref
Maria BjurbergEva HenrikssonEva BrunLars EkbladTomas OhlssonArne BrunElisabeth Kjellén. (2009) Early Changes in 2-Deoxy-2-[ 18 F]Fluoro- d -Glucose Metabolism in Squamous-Cell Carcinoma During Chemotherapy in Vivo and In Vitro . Cancer Biotherapy and Radiopharmaceuticals 24:3, pages 327-332.
Crossref
Takashi Yamatodani, Lars Ekblad, Elisabeth Kjellén, Anders Johnsson, Hiroyuki Mineta & Johan Wennerberg. (2008) Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines. Journal of Cancer Research and Clinical Oncology 135:3, pages 395-402.
Crossref
Xiaojian Zhou, Zhiyuan Zhang, Xiao Yang, Wantao Chen & Ping Zhang. (2009) Inhibition of cyclin D1 expression by cyclin D1 shRNAs in human oral squamous cell carcinoma cells is associated with increased cisplatin chemosensitivity. International Journal of Cancer 124:2, pages 483-489.
Crossref
Yoshimitsu Bamba, Tetsunari Nishikawa & Akio Tanaka. (2009) Expression of histone H3, p53, cyclin D1, and cyclin B1 in oral mucosal lesions. Oral Medicine & Pathology 13:4, pages 119-126.
Crossref
Jacques Bernier. (2008) Incorporation of Molecularly Targeted Agents in the Primary Treatment of Squamous Cell Carcinomas of the Head and Neck. Hematology/Oncology Clinics of North America 22:6, pages 1193-1208.
Crossref
Elisabetta Marangoni, Anne Vincent-Salomon, Nathalie Auger, Armelle Degeorges, Franck Assayag, Patricia de Cremoux, Ludmilla de Plater, Charlotte Guyader, Gonzague De Pinieux, Jean-Gabriel Judde, Magali Rebucci, Carine Tran-Perennou, Xavier Sastre-Garau, Brigitte Sigal-Zafrani, Olivier Delattre, Véronique Diéras & Marie-France Poupon. (2007) A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays. Clinical Cancer Research 13:13, pages 3989-3998.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.